WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005114187) METHODS AND COMPOSITIONS FOR DIAGNOSING AIDS AND OTHER DISEASES AND CONDITIONS INVOLVING IMMUNE SYSTEM ACTIVATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/114187    International Application No.:    PCT/US2005/013554
Publication Date: 01.12.2005 International Filing Date: 21.04.2005
IPC:
G01N 33/53 (2006.01), G01N 33/543 (2006.01), G01N 33/68 (2006.01)
Applicants: THE UNITED STATES OF AMERICA as represented by theSecretary, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; Office of Technology Transfer, NIH, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852 (US) (For All Designated States Except US).
SHEARER, Gene [US/US]; (US) (For US Only).
HERBEUVAL, Jean-Philippe [FR/US]; (US) (For US Only)
Inventors: SHEARER, Gene; (US).
HERBEUVAL, Jean-Philippe; (US)
Agent: AUERBACH, Jeffrey, I.; Berenato, White & Stavish, LLC, 6550 Rock Spring Drive, Suite 240, Bethesda, MD 20817 (US)
Priority Data:
60/564,588 23.04.2004 US
60/634,255 09.12.2004 US
Title (EN) METHODS AND COMPOSITIONS FOR DIAGNOSING AIDS AND OTHER DISEASES AND CONDITIONS INVOLVING IMMUNE SYSTEM ACTIVATION
(FR) PROCÉDÉS ET COMPOSITIONS DE DIAGNOSTIC DU SIDA ET D’AUTRES MALADIES ET CONDITIONS IMPLIQUANT L’ACTIVATION DU SYSTÈME IMMUNITAIRE
Abstract: front page image
(EN)This invention relates to methods and compositions suitable for monitoring the progression of AIDS, and other diseases whose progression involves immune system activation. In particular, the invention relates to the use of the TNF-Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Compounds to monitor the progression of AIDS, and other immune system diseases.
(FR)Cette invention concerne des procédés et compositions appropriés pour contrôler l’évolution du SIDA, et d’autres maladies dont l’évolution implique l’activation du système immunitaire. En particulier, l’invention concerne l’utilisation du ligand induisant l’apoptose médiée par TNF (TRAIL) et les composés TRAIL pour contrôler l’évolution du SIDA, et d’autres maladies du système immunitaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)